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Hematopoietic stem cells (HSCs) sustain blood
formation throughout life and are the functional units
of bone marrow transplantation. We show that
transient expression of six transcription factors
Run1t1, Hlf, Lmo2, Prdm5, Pbx1, and Zfp37 imparts
multilineage transplantation potential onto otherwise
committed lymphoid and myeloid progenitors and
myeloid effector cells. Inclusion of Mycn and Meis1
and use of polycistronic viruses increase reprogram-
ming efficacy. The reprogrammed cells, designated
induced-HSCs (iHSCs), possess clonal multilineage
differentiation potential, reconstitute stem/progeni-
tor compartments, and are serially transplantable.
Single-cell analysis revealed that iHSCs derived un-
der optimal conditions exhibit a gene expression
profile that is highly similar to endogenous HSCs.
These findings demonstrate that expression of a
set of defined factors is sufficient to activate the
gene networks governing HSC functional identity in
committed blood cells. Our results raise the prospect
that blood cell reprogramming may be a strategy for
derivation of transplantable stem cells for clinical
application.INTRODUCTION
Within the hematopoietic system, Hematopoietic stem cells
(HSCs) are the only cells with the functional capacity to differen-
tiate to all blood lineages, and to self-renew for life. These prop-
erties, in combination with the ability of HSCs to engraft condi-tioned recipients upon transplantation, have established the
paradigm for stem cell use in regenerative medicine. Allogeneic
and autologous HSC transplantation is used in the treatment
of 50,000 patients/year for congenital and acquired hemato-
poietic diseases and other malignancies (Gratwohl et al.,
2010). Despite wide clinical use, HSC transplantation has
inherent risks with transplantation outcomes impacted by multi-
ple factors including relapse of primary disease, the numbers of
HSCs transplanted, graft failure, and opportunistic infection.
Moreover, allogeneic transplantation often leads to graft versus
host disease (GVHD), a devastating T-cell-mediated condition
resulting from minor histoincompatibility differences between
donor and recipient. In spite of advances in HLA-typing to iden-
tify histocompatible donors, GVHD remains a significant cause
of morbidity and mortality for 60%–80% of patients receiving
grafts from unrelated donors (Petersdorf, 2013). De novo gener-
ation of isogenic HSCs from patient-derived cells would obviate
these issues, and extend transplantation to patients for whom a
histocompatible donor cannot be identified. Furthermore,
deriving HSCs from patients with hematological diseases would
be invaluable for gaining insights into disease etiology through
in vitro and in vivo disease modeling, as well as providing a
cell-based platform for therapeutic screening. Deriving HSCs
from alternative cell types has thus been a long sought goal in
regenerative medicine.
Considerable effort has been mounted toward developing
strategies for generating transplantable HSCs from alternative
cell types, such as pluripotent (ES/iPS) stem cells (Choi et al.,
2009; Kennedy et al., 2012). The advantages of using pluripotent
cells to derive HSCs are many and include the ease by which iPS
cells can be derived from patient cells, thereby putting autolo-
gous cell-based therapies within reach if HSCs can be success-
fully generated. However, despite considerable progress in
defining the developmental pathways leading to HSCs from
pluripotent cells (Sturgeon et al., 2013), the generation ofCell 157, 549–564, April 24, 2014 ª2014 Elsevier Inc. 549
robustly transplantable definitive HSCs from pluripotent cells re-
mains elusive. The developmental plasticity of fibroblasts and
success in converting them to other cell types has prompted
efforts to generate HSCs from these cells as an alternative strat-
egy to pluripotent stem-cell-based methodologies. In one study,
ectopic expression of OCT4 combined with the instructive sig-
nals of hematopoietic cytokines led to the generation of blood
cell progenitors from human fibroblasts, though the resulting
cells showed limited self-renewal potential and were unable to
give rise to all blood cell lineages (Szabo et al., 2010). More
recently, expression of Gata2, Gfi1b, cFos, and Etv6 in murine
fibroblasts led to the production of hematopoietic progenitors
through an endothelial-like cell intermediate, though the result-
ing cells ultimately did not possess HSC potential (Pereira
et al., 2013). In another study, expression of five transcription
factorsHOXA9,RORA, ERG, SOX4, andMYB imparted transient
myeloerythroid engraftment potential onto iPS-derived blood
cell progenitors, but were unable to instill the multilineage differ-
entiation and self-renewal potential characteristic of HSCs (Dou-
latov et al., 2013).
The reasons underlying the current inability to generate trans-
plantable HSCs from fibroblasts or pluripotent stem cells may be
many but likely include the failure of current ex vivo conditions to
support maintenance and propagation of HSCs. Moreover, the
epigenetic landscape underlying HSC functional identity may
be difficult to establish from divergent lineages such as fibro-
blasts or pluripotent stem cells. An alternative strategy that has
the potential to surmount such challenges would be to repro-
gram differentiated blood cells back to HSCs. Striking examples
in which hematopoietic cells have been experimentally reprog-
rammed to alternative blood cell fates by forced expression or
ablation of lineage-affiliated transcription factors (Choi et al.,
1990; Hanna et al., 2008; Iwasaki et al., 2006; Laiosa et al.,
2006; Rolink et al., 1999; Taghon et al., 2007; Xie et al., 2004)
demonstrate that cells of the hematopoietic system are
amenable to reprogramming to alternative fates. Indeed, studies
by Busslinger and colleagues have shown that ablation of a sin-
gle transcription factor, Pax5, in early B cell progenitors (Nutt
et al., 1999; Rolink et al., 1999), or terminally differentiated B cells
(Cobaleda et al., 2007) was sufficient to dedifferentiate these
cells to a primitive progenitor state that possessed multilineage
myeloid and T cell potential but ultimately did not possess
HSC activity. Pax5 ablation in peripheral B cells also led to the
formation of highly penetrant and aggressive lymphomas in vivo
(Cobaleda et al., 2007) thus limiting prospects for translating
Pax5 ablation as a strategy to derive engraftable multilineage
progenitors.
HSCs rely on complex gene regulatory networks to enable
their full functional potential (Orkin and Zon, 2008). Cell fate re-
programming studies including those mentioned above have
however demonstrated that ectopic expression of surprisingly
few regulators is often sufficient to rewrite the gene networks
regulating cell identity for many cell types. We hypothesized
that the regulatory networks governing HSC identity might simi-
larly be accessed through the action of a small number of genes,
and if so, that the functional identity of HSCs might be endowed
to downstream blood cells upon ectopic expression of such
factors. In this study, we have used the approach of transcrip-550 Cell 157, 549–564, April 24, 2014 ª2014 Elsevier Inc.tion-factor-mediated cellular reprogramming within the hemato-
poietic system to derive transplantable HSC-like cells that
possess the functional and molecular properties of HSCs.
RESULTS
Identification of Factors Capable of Imparting
Alternative Lineage Potential In Vitro and Multilineage
Engraftment Potential onCommittedProgenitors In Vivo
Experimental strategies for reprogramming diverse cell types
generally rely on the action of one or more genes to impart the
cellular and molecular properties of one cell type onto a different
cell type. We reasoned that regulatory factors with relatively
restricted expression in HSCs in relation to their downstream
hematopoietic progeny are likely to be involved in defining the
functional identity of HSCs through regulation of the gene net-
works underlying their fundamental properties. We therefore hy-
pothesized that transient ectopic expression of such factors in
committed blood cells might therefore endow them with the
functional potential of HSCs and potentially stably reprogram
them back to an HSC-like state. To identify such factors in an un-
biased manner, we analyzed microarray data of 40 different
hematopoietic cell types that others and we have generated
comprising themajority of hematopoietic progenitor and effector
cells in addition to HSCs. These data sets (142 arrays in total)
were normalized into a single database through which we iden-
tified 36 regulatory factors with relatively restricted expression in
HSCs (Figure 1A, Table S1). These included 33 genes encoding
transcription factors, and 3 genes encoding translational regula-
tors, many of which have been previously identified in studies
profiling different hematopoietic cell types to define HSC tran-
scriptional signatures (Chambers et al., 2007; Gazit et al.,
2013). In addition to genes with known roles in regulating
HSCs suchNdn,Evi1,Meis1, and Egr1, we also identified several
genes that remain unstudied in HSC biology. The 36 factors were
then cloned into doxycycline-inducible lentiviruses bearing a re-
porter cassette (Zs-Green) and high-titer viruses produced
(Figure 1B).
It has been recognized that one of the challenges to reprog-
ramming mature cells is that they are inherently stable. This is
not necessarily true of oligo-potent and lineage-committed he-
matopoietic progenitors, which are in the process of differentia-
tion. Moreover, since progenitor cells proximal to HSCs aremore
epigenetically related to HSCs (Bock et al., 2012), we reasoned
that such proximity might be leveraged to lower the epigenetic
barriers to HSC derivation. We first sought to determine if we
could impart myeloid lineage potential onto otherwise B cell
restricted progenitors by expression of the 36 factors. Toward
this, we purified pro-/pre-B cells (CD19+B220+AA4.1+IgM)
from mice expressing the reverse tetracycline-controlled trans-
activator (rtTA) from the Rosa26 locus (Rosa26rtTA) (Figure S1
available online), and transduced them with control virus (Zs-
green), or the 36-factor viral cocktail. Transduced cells were
then cultured in the presence of doxycycline for 2 days followed
by plating into methylcellulose in the presence of myeloid pro-
moting cytokines, as well Flt3L and IL7 to promote B cell survival
(Figure 1C). These experiments showed that, whereas control-
transduced pro-/pre-B cells were unable to form myeloid
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Figure 1. Identification of Factors Capable of Imparting Alternative Lineage Potential In Vitro
(A) Heat map showing relative expression (green;high, to purple;low) of 36 regulatory genes identified as HSC-specific in the indicated cell types (see also
Table S1).
(B) Schematic representation of lentivirus transgene expression cassette (top), and flow cytometry plots showing reporter cassette (ZsGr) expression in pro-/pre-
B cells ± doxycycline induction (48 hr post).
(C) Schematic representation of in vitro screening strategy for cell fate conversion.
(D) Representative images of wells showing colonies arising in methylcellulose from pro-/pre-B cells transduced with ZsGr or 36-factor cocktail.
(E) Colony number and type arising in methylcellulose from pro-/pre-B cells transduced with ZsGr or 36-factor cocktail. Four independent experiments are shown
and each condition performed in triplicate. Error bars represent SD.
See also Table S1.colonies as expected, cells transduced with the 36-factor cock-
tail readily gave rise to colonies containing diverse myeloid line-
ages including granulocytes, erythrocytes, megakaryocytes,
and macrophages (Figures 1D and 1E).
We next determined if transient ectopic expression of the
36-factor cocktail imparted HSC-like potential onto lineage-
restricted lymphoid or myeloid progenitors in vivo. We took
advantage of the fact that HSCs are the only hematopoietic cells
capable of long-termmultilineage reconstitution in myeloablated
recipients upon transplantation, and progenitors transduced
with a combination of factors able to instill them with long-term
reconstitution potential would be readily detected in these
assays (Figure 2A). Moreover, the sensitivity of transplantation
is such that the activity of even a single HSC can read out, sug-
gesting that even rare reprogramming events might be evi-
denced. Moreover, we reasoned that an in vivo setting couldprovide access to cues present in the microenvironment of the
hematopoietic system that might facilitate or even be required
for reprogramming. For these experiments we purified pro-/
pre-B cells or common myeloid progenitors (CMPs: linc-kit+
Sca1FcgrlowCD34+) from Rosa26rtTA mice (CD45.2) and fol-
lowing a 2 day transduction protocol with control (Zs-green) or
viruses bearing the 36 factors in the presence of doxycycline,
we competitively transplanted them along with whole-bone
marrow cells (CD45.1) into lethally irradiated congenic recipients
(CD45.1) (Figure 2A). Doxycycline was maintained in the drinking
water for 2 weeks posttransplant to maintain ectopic expression
of the introduced factors, followed by doxycycline withdrawal.
Peripheral blood analysis of the reconstituted mice over the
16 week course of the experiment revealed that, as expected,
control-transduced pro-/pre-B cells or CMPs did not give rise
to long-term engraftment (Figures 2B and 2C). By contrast, aCell 157, 549–564, April 24, 2014 ª2014 Elsevier Inc. 551
A B
C
D
E F
G
Figure 2. Identification of Factors Capable of Imparting Multilineage Engraftment Potential onto Committed Progenitors In Vivo
(A) Schematic of experimental strategy to identify factors capable of imparting multilineage engraftment potential on committed progenitors in vivo.
(B) Representative flow cytometry plots showing donor (CD45.2) reconstitution of mice transplanted with control (ZsGr) or 36-factor transduced pro-/pre-B cells
or CMPs 16 weeks posttransplant.
(legend continued on next page)
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few of the recipients transplanted with the 36-factor transduced
B cell progenitors (3/15) or CMPs (2/8) exhibited long-term
donor-derived reconstitution (Figures 2B and 2C, S2A). All but
one of the reconstituted mice showed multilineage engraftment
of B, T and myeloid cells though the degree of engraftment of
each lineage varied among the different recipients (Figure 2D).
Donor-derived cells were found to be negative for expression
of the reporter gene present in all viruses indicating an absence
of continued factor expression post-dox-induction (Figure S2A).
Analysis of V(D)J recombination in sorted donor-derived myeloid
cells from the pro-/pre-B cell arm of the experiment confirmed
the B-lineage origin of the reconstituting cells as evidenced by
recombination of the heavy chain of the Ig locus (Figure 2E).
The observation of multiple bands in the gel indicated that the re-
constituting cells were polyclonal.
These experiments indicated that one ormore factors from the
36-factor cocktail could imbue multilineage reconstituting po-
tential onto otherwise committed lymphoid and myeloid progen-
itors. To determine which factors might be involved in conferring
this potential, we sorted donor-derived myeloid, B and T cells to
test for the presence of each of the 36 factors using a PCR-
based strategy (Figure 2F, Table S2). This analysis revealed
that whereas multiple factors could be identified in the donor-
derived cells from each of the reconstituted mice, six transcrip-
tion factors, Hlf, Runx1t1, Pbx1, Lmo2, Zfp37, and Prdm5 were
consistently detected in the reconstituted recipients in multiple
lineages (Figure 2G).
Transient Ectopic Expression of Six Transcription
Factors in Committed Progenitors Is Sufficient to Alter
Lineage Potential In Vitro and Impart Long-Term
Multilineage Engraftment Potential In Vivo
We next assessed if the six transcription factors we had identi-
fied in our in vivo screen were sufficient to confer myeloid colony
forming potential onto pro-/pre-B cells in methylcellulose. As we
had observed with the 36-factor cocktail (Figures 1D and 1E),
transduction with the viral combination of Hlf, Runx1t1, Pbx1,
Lmo2, Zfp37, and Prdm5 was able to imbue lineage-restricted
B cell progenitors with myeloid lineage potential in these assays
while also augmenting the ability of the cells to give rise to B cell
colonies (Figures 3A and 3B). To test the requirement for each of
the six transcription factors (6-TF), we performed ‘‘N minus 1’’
experiments in which each of the factors was sequentially
omitted from the transduction cocktail (Figure 3C). These exper-
iments revealed that whereas Hlf, Runx1t1, Pbx1, Lmo2, and
Zfp37 were all required for instilling myeloid colony forming po-
tential onto pro-/pre-B cells in vitro, the 5-factor cocktail minus(C) Donor reconstitution of mice transplanted with ZsGr or 36-factor transduced p
with >1% donor chimerism (dotted line) were considered reconstituted. Recipien
n = 8, and CMP;36 factor n = 8.
(D) Reconstitution of indicated peripheral blood cell lineages of individual recipie
(E) PCR analysis of immunoglobulin rearrangement showing heavy (JH), and lig
progenitor (LSK) cells, myeloid progenitors (Myl Pro), and peripheral blood (PB) c
myeloid cells (Mac1+ Donor) originating from pro-/pre-B cell;36-factor experime
(F) PCR-based strategy to identify virally integrated factors and discriminate from
(G) Summary of data showing presence (yellow) or absence (black) of each of the
mice shown in (C).
See also Figures S1 and S2.Prdm5 gave rise to myeloid colonies albeit at lower numbers
than the 6-TF combination (Figure 3C).
We next tested whether transient expression of these six tran-
scription factors was sufficient to impart long-term reconstituting
potential onto committed myeloid or B cell progenitors in
competitive transplantation assays. Purified pro-/pre-B cells or
CMPs were transduced with control (Zs-Green) virus or the
6-TF cocktail followed by transplantation into congenic recipi-
ents (CD45.1). In contrast to control-transduced cells, long-
term multilineage reconstitution was observed in 1/13 and 2/12
recipients transplanted with 6-TF transduced pro-/pre-B cells
or CMPs cells, respectively (Figures 3D). Peripheral blood anal-
ysis of recipient mice throughout the course of the experiment
revealed that in all cases, donor-derived cells from the reconsti-
tuted recipients showed multilineage engraftment (Figures 3D–
3F and S2B). Ig heavy chain rearrangement was observed in
donor-derived myeloid cells sorted from the pro-/pre-B cell re-
constituted mouse confirming the B cell origin of the reconstitut-
ing cells (Figure 3G). These results indicate that transient ectopic
expression of Hlf, Runx1t1, Pbx1, Lmo2, and Zfp37, and Prdm5
is sufficient to impart long-term, multilineage transplantation
potential onto otherwise committed myeloid and lymphoid
progenitors.
Inclusion ofMeis1 and Mycn and Use of Polycistronic
Viruses Improves In Vivo Reprogramming Efficiency
The absence of donor-derived reconstitution in many of the
recipientmice inour6-TF transplantation experiments (Figure3D)
suggested that the efficiency of conferring long-term multiline-
age potential onto committed progenitors was low. In order to in-
crease the probability that target cells would be cotransduced
with all the factors we developed polycistronic doxycycline-
inducible lentiviruses bearing three transcription factors each
separated by 2A peptide sequences (Runx1T1dHlfdLmo2 [RHL],
Pbx1dZfp37dPrdm5 [PZP]). We also included two additional tran-
scription factors (Mycn and Meis1) that we had repeatedly iden-
tified from primitive colonies generated in in vitro colony forming
experiments (Figures 4A andS3, and data not shown). To test the
utility of these strategies, we transduced purified pro-/pre-B cells
(CD45.1) with control virus, or the 8-transcription factor cocktail
as individual viruses (8-TF), or using the RHL and PZP polycis-
tronic viruses along with viruses bearing Mycn and Meis1
(8-TFPoly), and transplanted them along with Sca1-depleted
(CD45.2) marrow into irradiated congenic recipients (CD45.2).
Peripheral blood analysis of transplanted mice over the course
of 16 weeks revealed that in contrast to the control-transduced
cells that showed no donor-derived chimerism (0/12), multiplero-/pre-B cells or CMPs at indicated time points posttransplantation. Only mice
ts transplanted; Pro/PreB;ZsGr n = 15, Pro/PreB;36 factor n = 15, CMP;ZsGr
nts showing >1% donor chimerism presented as percentage (%) of donor.
ht chain (JLl, JLk) in bone marrow (BM) cells including B cells (B220+), stem/
ells including B cells (B220+), recipient myeloid cells (Mac1+ Rec), and donor
nt. Loading control; genomic PCR for CD45.
endogenous genes.
indicated factors in donor B, T, and myeloid cells in each of the reconstituted
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Figure 3. Transient Ectopic Expression of Six Transcription Factors in Committed Progenitors Is Sufficient to Alter Lineage Potential In Vitro
and Impart Long-Term Engraftment Potential on Committed Progenitors In Vivo
(A) Representative images of wells showing colonies arising in methylcellulose from pro-/pre-B cells transduced with ZsGr or 6-TF cocktail.
(B) Colony number and indicated colony type arising in methylcellulose from pro-/pre-B cells transduced with ZsGr or 6-TF cocktail. Three independent ex-
periments are shown with each condition performed in triplicate.
(C) Colony number and type arising in methylcellulose from pro-/pre-B cells transduced with ZsGr, 6-TF cocktail, or 6-TF minus the indicated factor. Each
condition performed in triplicate.
(D) Donor reconstitution of mice transplanted with ZsGr or 6-TF transduced pro-/pre-B cells or CMPs at indicated time points posttransplantation. Only mice
with >1% donor chimerism (dotted line) were considered reconstituted. Recipients transplanted; Pro/PreB;ZsGr n = 10, Pro/PreB;6-TF n = 12, CMP;ZsGr n = 9,
and CMP;6-TF n = 9.
(E) Representative flow cytometry plots showing donor reconstitution and lineage composition of mice transplanted with control (ZsGr) or 6-TF transduced pro-/
pre-B cells or CMPs 16 weeks posttransplant. Lineage contribution to Mac1+ myeloid cells, B220+ B cells, and CD3/4/8+ T cells is shown.
(F) Reconstitution of indicated peripheral blood cell lineages of individual recipients showing >1% donor chimerism presented as percentage (%) of donor.
(G) PCR analysis of immunoglobulin heavy (JH) chain rearrangement in recipient myeloid cells (Mac1+ Rec), and donor myeloid cells (Mac1+ Donor) originating
from pro-/pre-B cell;6-TF experiment. Loading control; genomic PCR for CD45.
Error bars in panels (B) and (C) represent SD. See also Figure S2.
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recipients transplanted with either the 8-TF (3/6) or the 8-TFPoly
(9/14) transduced cells exhibited donor-derived chimerism (Fig-
ure 4B). All recipients showed multilineage reconstitution 18–
22 weeks posttransplant though again the degree of B cell,
T cell, and myeloid chimerism varied among recipients (Figures
4C and 4D and S2C). The B cell origin of the reconstituting cells
was confirmed through evidence of Ig heavy chain rearrange-
ment in donor-derived myeloid cells (Figure 4E).
Reprogrammed Cells Engraft Bone Marrow Progenitor
Compartments and Can Reconstitute Secondary
Recipients
In addition to reconstituting the peripheral blood, HSCs effi-
ciently repopulate secondary hematopoietic organs and bone
marrow progenitor cell compartments upon transplantation.
To determine if the B cell progenitors transduced with the 8-
TF or 8-TFPoly cocktails possessed this ability, reconstituted
mice were sacrificed and analyzed 18–20 weeks posttrans-
plant, showing that all the mice had donor-derived chimerism
of the bone marrow, spleen and thymus though the level of
chimerism varied between recipients as we had observed in
the peripheral blood (Figures 5A). The pro-/pre-B cell origin of
the engrafting cells was confirmed through analysis of Ig rear-
rangement from DNA isolated from granulocytes and myeloid
cells purified from the bone marrow and spleen, and T cells
derived from the thymus (Figure 5B). Immunophenotyping of
bone marrow cells revealed donor contribution to common
lymphoid progenitors (CLPs: linFlk2+IL7Ra+ckitlowSca1low),
CMPs, granulocyte/monocyte progenitors (GMPs: linckit+
Sca1FcgRhighCD34+), megarkaryocyte/erythrocyte progenitors
(MEPs: linckit+Sca1FcgRCD34), and primitive LSK pro-
genitors (linSca1+ckit+) (Figures 5C–5F), which were compara-
ble to host-derived progenitors analyzed from the same mice
(Figures S4A and S4B). Importantly, we also observed donor
contribution to megakaryocyte progenitors (MkPs: linc-kit+
Sca1CD41+) and erythroid progenitors (EPs: linckit+Sca1
Endoglin+), demonstrating that the reconstituting cells were
able of give rise to precursor cells of platelets and erythrocytes.
Radioprotection transplantation assays performed using donor-
derived MEPs (Na Nakorn et al., 2002) confirmed that the
reprogrammed cells possessed a robust ability to generate
platelets and red blood cells in vivo (Figures S4C and S4D).
Importantly, subfractionation of the LSK compartment revealed
donor-derived reconstitution of the multipotent progenitor
(MPP1: linckit+Sca1+CD34+Flk2, MPP2: linc-kit+Sca1+
CD34+Flk2+) and HSC (linc-kit+Sca1+CD34Flk2) compart-
ments (Figures 5C, 5D, and 5F). Donor-marked progenitors
and HSCs were subsequently analyzed for V(D)J recombination,
which revealed Ig heavy chain rearrangement confirming their B
cell origin (Figure 5G).
A defining property of HSCs is their ability to self-renew, a po-
tential that can be evidenced by an ability to reconstitute sec-
ondary recipients upon serial transplantation. To test if the cells
generated in our experiments possessed this potential we sacri-
ficed primary recipient mice 18 weeks posttransplant and trans-
planted unsorted whole-bone marrow or c-kit+ cells into
irradiated secondary congenic recipients. Peripheral blood anal-
ysis at long-term time points posttransplant (16–22 weeks), re-vealed donor reconstitution of B, T, and myeloid cells in all sec-
ondary recipients (Figures 5H and 5I).
In addition to sustained self-renewal potential, a hallmark
property of HSCs is their ability to give rise to multilineage differ-
entiation at the clonal level. Although we had observed clonal
multilineage differentiation potential in vitro after induction of
our factors (Figures 3B and 3C), our in vivo transplantation ex-
periments, which were done at the population level, precluded
us from concluding clonal differentiation potential in vivo. We
reasoned that Ig heavy chain rearrangements arising in pro-/
pre-B cells could be used as a bar code that could be used to
trace the clonal origin of donor-derived cells. We therefore iso-
lated DNA from sorted donor-derived B and T cells, granulo-
cytes, and macrophage/monocytes from primary recipients
transplanted with pro-/pre-B cells transduced with either 8-TF
single or polycistronic viral cocktails (8-TF, 8-TFPoly). Ig heavy
chain-specific PCR spanning the V(D)J junction was then per-
formed and products common in size to all lineages analyzed
were gel purified, cloned and sequenced. Analysis of these se-
quences revealed unique V(D)J junction sequences common to
all four donor-derived lineages analyzed from three independent
donors (Figure S5A). These results provide strong evidence that
a single reprogrammed cell possessed multilineage differentia-
tion potential, though there is an extremely remote possibility
that these results could reflect the contribution of cells bearing
identical V(D)J junctions. Using the same approach, we next
analyzed DNA isolated from FACS purified donor-derived
Mac1+ myeloid cells, B cells, and T cells from secondary recip-
ients that had been transplanted with the bone marrow of one of
the mice we had analyzed during primary transplant. We identi-
fied the same V(D)J junction in the donor-derived myeloid, B and
T cells of the secondary recipient, that had been previously
identified in the primary recipient (Figure S5B). From these ex-
periments we conclude that reprogrammed cells possess self-
renewal and multilineage differentiation potential at the clonal
level.
Taken together, these results demonstrate that transient
ectopic expression of eight transcription factors in lineage-
restricted B cell progenitors imparts them with the functional
hallmarks of HSCs including clonal multilineage reconstituting
potential, capacity to reconstitute bone marrow stem and pro-
genitor cell compartments, and long-term self-renewal potential.
Transient Expression of Defined Transcription Factors
in Myeloid Effector Cells Is Sufficient to Instill Them
Long-Term Multilineage Transplantation Potential
In Vivo
Eventual clinical translation of blood cell reprogramming to
derive HSCswould benefit from an ability to reprogram cell types
that can be readily and noninvasively obtained from the periph-
eral blood. We therefore sought to determine if multilineage pro-
genitor activity could be conferred onto terminally differentiated
blood cells using the transcription factors we identified. To test
this, recipient and donor-derived peripheral blood was sorted
from mice engrafted with pro-/pre-B cells transduced with the
8-factor cocktail (8-TF or 8TFPoly) 16–22 weeks posttransplant.
Sorted cells were then cultured in the absence or presence of
doxycycline—with the latter condition expected to reinduceCell 157, 549–564, April 24, 2014 ª2014 Elsevier Inc. 555
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Figure 4. Inclusion of Meis1 and Mycn and Use of Polycistronic Viruses Improves In Vivo Reprogramming Efficiency
(A) Schematic representation of RHL (Runxt1t1, Hlf, Lmo2) and PZP (Pbx1, Zfp37, Prdm5) polycistronic, and Meis1 and Mycn single factor viral constructs.
(B) Donor reconstitution of mice transplanted with ZsGr, 8-TF (eight single factor viruses), or 8-TFPoly (RHL, PZP polycistronic viruses plus Meis1 and Mycn
viruses), transduced pro-/pre-B cells at indicated time points posttransplantation. Only mice with >1% donor chimerism were considered reconstituted.
Recipients transplanted; ZsGr; n = 12, 8-TF; n = 6, 8TFPoly; n = 14.
(C) Representative flow cytometry plots showing donor reconstitution and lineage contribution of mice transplanted with control (ZsGr), 8-TF, or 8TFPoly
transduced pro-/pre-B cells 16 weeks posttransplant. Lineage contribution toMac1+GR1-myeloid cells, Mac+GR1+ granulocytes, B220+ B cells, and CD3/4/8+
T cells is shown.
(legend continued on next page)
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expression of the transduced factors—followed by plating the
cells in methylcellulose (Figure 6A). As expected, neither the
recipient-marked cells, nor the donor-derived cells cultured
and plated in the absence of doxycycline gave rise to colonies
(Figure 6B). By contrast, plates seeded with donor cells that
had seen reactivation of the eight transcription factors by expo-
sure to doxycycline gave rise to mixed myeloid lineage colonies
(Figure 6B). To determine which lineage(s) in the peripheral blood
had the potential to give rise to these colonies upon re-expres-
sion of the transduced transcription factors, we purified B cells,
T cells, myeloid cells, and granulocytes from 8-TFPoly reconsti-
tuted mice, and tested their colony forming potential following
culturing and plating in the absence or presence of doxycycline.
Strikingly, plates seeded with each of the four peripheral blood
cell types all developed colonies in the presence of dox, indi-
cating that progenitor activity had been instilled into single cells
upon reinduction of the factors. Of these, granulocytes gave rise
to the fewest colonies whereas Mac1+ macrophages/mono-
cytes yielded the largest number of colonies and the greatest
number of primitive GEMM colonies (Figures 6C and 6D).
Encouraged by these results, we next sought to determine if
the transcription factors we identified could impart multilineage
reconstituting potential onto terminally differentiated cells in
transplantation assays. We focused on differentiated myeloid
cells because unlike differentiated lymphoid cells that have rear-
ranged TCR (T cells) or Ig (B cells) loci, multilineage reconstitut-
ing cells derived via reprogramming of myeloid cells would be
expected to have the potential to give rise to full repertoires of
lymphoid effector cells upon differentiation. We therefore sorted
Mac1+c-kit myeloid effector cells, which include monocytes,
macrophages, and granulocytes, from Rosa26rtTA mice and
transduced themwith either 6-factor (6-TFPoly), or 8-factor cock-
tails (8-TF and 8-TFPoly) and transplanted them into irradiated
congenic recipients. Peripheral blood analysis at monthly inter-
vals revealed that, whereas none of mice transplanted with cells
transduced with control virus were reconstituted, multiple recip-
ients transplanted with cells transduced with 6-TFPoly (4/7), 8-TF
(3/6), and 8-TFPoly (7/8) exhibited long-term donor-derived
engraftment (Figures 6F and S6A). Lineage analysis of the recon-
stitutedmice showed donor-derived contribution to B cell, T cell,
myeloid, and granulocyte lineages with contribution to each line-
age varying between recipients (Figures 6F and S2D). Donor-
derived contribution to secondary hematopoietic organs, and
bone marrow progenitor cell compartments was also observed
in mice sacrificed and analyzed 20 weeks posttransplant (Fig-
ures S6B and S6C). Serial transplantation of sorted donor-
derived bone marrow cells demonstrated that the 6-TF or 8-TF
transducedmyeloid effectors could engraft secondary recipients
in all lineages to 16 weeks posttransplant (Figures 6G and 6H).
Based on the functional data presented in Figures 1, 2, 3, 4, 5,
6 we conclude that transient ectopic expression of six (Hlf,
Runx1t1, Pbx1, Lmo2, Zfp37, and Prdm5) or eight (Hlf, Runx1t1,
Pbx1, Lmo2, and Zfp37, Prdm5, Mycn, and Meis1) transcription(D) Reconstitution of indicated peripheral blood cell lineages of individual re
donor.
(E) PCR analysis of immunoglobulin heavy (JH) chain rearrangement in recipient (Re
See also Figures S2 and S3 and Table S2.factors is sufficient to reprogram differentiated hematopoietic
progenitors and effector cells to cells that possess the functional
properties of HSCs. We term these reprogrammed cells
induced-HSCs (iHSCs).
Single-Cell Expression Profiling of iHSCs Reveals
Evidence of Partial and Full Reprogramming
To assess the extent to which reprogrammed iHSCs recapitulate
the molecular properties of endogenous HSCs, we employed
a recently developed single cell gene expression profiling meth-
odology that accurately defines hematopoietic stem and pro-
genitor identity through the simultaneous quantification of
expression of 151 lineage-specific transcription factors, epige-
netic modifiers, cell surface molecules, and cell-cycle regulators
(Guo et al., 2013). We sorted and analyzed donor-derived
iHSCs by immunophenotype (CD45.2+lineageckit+Sca1+Fk2
CD34/lowCD150+) 18 weeks posttransplantation from two
different experiments in which pro-/pre-B cells had been trans-
duced with the 8-TF cocktail as single viruses (8-TF), or with
polycistronic viruses (8-TFPoly) (Figure 4). We also sorted and
analyzed host-derived HSCs (CD45.1+lineageckit+Sca1+Fk2
CD34/lowCD150+) from the samemice to serve as controls. Sin-
gle-cell expression data generated from iHSCs and host HSCs
was then analyzed in comparison to data generated from pro-/
pre-B cells (the starting cell type), and also to data previously
generated from HSCs, MPPs, CLPs, CMPs, GMPs, and MEPs
purified at steady-state (Guo et al., 2013). Analysis of the raw
data revealed high correlation between gene expression for the
vast majority of control and test cell types (Figure S7, Table
S3). To interrogate the transcriptional relationships among all
the cell types analyzed, we performed principal component anal-
ysis (PCA) to define the transcriptional distances between the
cells. As expected, steady-state HSCs and progenitor cells
were largely positioned in agreement with established lineal rela-
tionships with HSCs forming a clearly defined cluster, and with
MPPs positioned proximal, and oligopotent progenitors (MEPs,
GMPs, CLPs) positioned more distal to HSCs (Figure 7A). pro-/
pre-B cells positioned closely to CLPs consistent with the lineal
relationship between these cell types, while the host-derived
HSCs were positioned within the steady-state HSC cluster as
expected (Figure 7A). Interestingly, iHSCs derived from the two
experiments (8-TF or 8-TFPoly) exhibited very distinct patterns
of expression with the iHSCs derived from the 8-TF single virus
experiment being more heterogeneous than the iHSCs derived
from the 8-TFPoly transduced cells (Figures 7A and S7 and Table
S3). Whereas some of the iHSCs 8-TF positioned closely or
within the HSC cluster, others mapped closer to MPPs while
others positioned closely to the pro-/pre-B cluster (Figure 7A).
By contrast, all of the iHSCs derived using the polycistronic vir-
sues (iHSC 8-TFPoly) clustered within the HSC node (Figure 7A).
Unsupervised hierarchical clustering analysis showed that
whereas approximately equal numbers of iHSCs derived using
single 8-TF viruses mapped closely to HSCs (6/23), otherscipients showing >1% donor chimerism presented as percentage (%) of
cip), and donor (Donor) myeloid cells. Loading control; genomic PCR for CD45.
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Figure 5. Reprogrammed Cells Engraft Secondary Hematopoietic Organs, Bone Marrow Progenitor Compartments and Reconstitute
Secondary Recipients
(A) Donor reconstitution of peripheral blood (PB), bone marrow (BM), spleen, and thymus of mice transplanted with 8-TF or 8-TFPoly transduced pro-/pre-B cells
18–20 weeks posttransplantation.
(legend continued on next page)
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mapped closely to MPPs (7/23), while the remainder mapped
more closely to pro-/pre-B cells (10/23) (Figure 7B). In contrast,
all of the iHSCs derived using polycistronic viruses clustered very
closely to host and control HSCs (35/35).
The inclusion of five (Mycn, Hlf, Lmo2,Meis1, and Pbx1) of the
eight reprogramming factors among the 151 genes analyzed in
these experiments allowed us to address how endogenous
levels of these factors was re-established in iHSCs postreprog-
ramming. Consistent with their known roles in regulating HSCs,
high levels of each ofMycn,Hlf, Lmo2, andMeis1were observed
in steady-state HSCs, which contrasted the low levels observed
in pro-/pre-B cells (Figure 7C). Pbx1 expression was lower in the
majority of HSCs and absent in pro-/pre-B cells. Conversely,
Ebf1 and Pax5, which are critical transcription factors for B cell
development were expressed at high levels in pro-/pre-B cells
and negligible levels in HSCs. Analysis of the expression of these
genes in iHSCs again revealed distinct differences depending
upon whether or not single or polycistronic viruses were used
for their derivation. Whereas high levels of endogenous Mycn,
Hlf, Lmo2, Meis1, and moderate levels of Pbx1 was reestab-
lished in many of the iHSCs derived using single viruses, low
levels of these genes and high levels of Ebf1 and Pax5 were still
observed in a significant fraction of the cells (Figure 7C). By
contrast, the expression of each of these genes in iHSCs derived
using the polycistronic viruses closely recapitulated the expres-
sion patterns observed in the control HSCs (Figure 7C), as did
the expression of all other genes analyzed known to be critical
for HSCs function including the transcription factors Gfi1b,
Gata2, and Ndn, and the cytokine receptors Mpl, and c-kit (Fig-
ure 7C and Table S3). Taken together, these results demonstrate
that 8-TF reprogramming of pro-/pre-B using single viruses gen-
erates iHSCs with transcriptional properties consistent with
either full or partial reprogramming, whereas iHSCs derived un-
der optimal polycistronic viral conditions exhibit an expression
profile highly similar with HSCs.
DISCUSSION
The de novo generation of transplantable HSCs has been a long
sought goal in regenerative medicine. Here we report the gener-
ation of induced-HSCs via reprogramming from committed he-
matopoietic progenitor and effector cells. Through functional
screening of 36 HSC-enriched factors, we identified six tran-(B) PCR analysis of immunoglobulin heavy (JH) chain rearrangement in recipient
Mac1+GR1+ granulocytes (G), and T cells (T). Loading control; genomic PCR fo
(C) Representative bonemarrow stem and progenitor analysis of a recipient transp
showing donor-reconstitution of myeloid progenitors (Myl Pro), megarkaryocy
common myeloid progenitors (CMP), megakaryocyte progenitors (MkP), erythr
Sca1+ckit+ multipotent progenitors (LSK), multipotent progenitors (MPP1, MPP2
discriminated, live (propidium-iodide-negative), and lineage-negative cells.
(D) Total donor reconstitution of the indicated populations in mice analyzed in (A
(E and F) Reconstitution of the indicated myeloid progenitor (E) and primitive m
percentage of donor.
(G) PCR analysis of immunoglobulin heavy (JH) chain rearrangement in the indica
(H) Donor reconstitution of secondary recipient mice transplanted with whole-b
transplants of 8-TF transduced pro-/pre-B cells analyzed at 16–22 weeks. Numbe
reconstitution level of primary recipient.
(I) Reconstitution of indicated peripheral blood cell lineages of individual recipien
See also Figures S2, S4, S5.scription factors Hlf, Runx1t1, Pbx1, Lmo2, Zfp37, and Prdm5
whose transient ectopic expression was sufficient to impart
HSC functional potential onto committed blood cells in vivo. In-
clusion of two additional transcription factors, Mycn and Meis1,
and the use of polycistronic viruses increased reprogramming
efficiency. Reprogrammed cells showedmultilineage differentia-
tion and extensive self-renewal at the clonal level, and continued
ectopic expression of the virally transduced reprogramming fac-
tors was not required to sustain the functional potential of the re-
programmed cells in vivo (Figure S2). These findings demon-
strate that ectopic expression of a set of defined transcription
factors in committed blood cells is sufficient to stably activate
the gene regulatory networks governing HSC functional identity.
HSCs are the most well-characterized tissue-specific stem
cells yet surprisingly little is known about the molecular mecha-
nisms involved in regulating their central properties. The identifi-
cation of a defined set of transcription factors capable of stably
imparting HSC potential onto otherwise non-self-renewing, line-
age-restricted cells, implies that these factors may be critically
involved in regulating the transcriptional networks underlying
HSC functional identity. Consistent with this, several of the fac-
tors that we identified have previously been established to regu-
late diverse aspects of HSC biology. For example, Pbx1 and
Meis1, which interact and can form heterodimeric and heterotri-
meric complexes with HOX proteins, regulate HSC self-renewal
by maintaining HSC quiescence (Ficara et al., 2008; Kocabas
et al., 2012; Unnisa et al., 2012). Lmo2 is required for hematopoi-
esis, and in its absence, neither primitive or definitive blood cells
form (Warren et al., 1994; Yamada et al., 1998). And whileMycn
is dispensable for HSC activity due to functional redundancy
with Myc, combined ablation of both severely disrupts HSC
self-renewal and differentiation potential (Laurenti et al., 2008).
In contrast to these well-characterized genes, Prdm5 and
Zfp37 remain unstudied in HSC biology, and although the role
of RUNX1T1 (as known as ETO) as a fusion partner with
RUNX1 in acute myeloid leukemia is well established, its role in
normal hematopoiesis remains unclear. Defining the roles that
each of the reprogramming factors play in normal HSC biology
will be critical for understanding their function in blood cell
reprogramming.
Going forward it will also be important to elucidate how the re-
programming factors activate and maintain HSC transcriptional
networks. The fact that six of the eight factors we identified(R), and donor (D) cells. Cell types analyzed include Mac1+ myeloid cells (M),
r CD45.
lanted with 8-TFPoly transduced pro-/pre-B cells 18 weeks posttransplantation
te/erythrocyte progenitors (MEP), granulocyte/monocyte progenitors (GMP),
oid progenitors (EP), common lymphoid progenitors (CLP), Lineage-negative
), and hematopoietic stem cells (HSC). All cells were pregated through doublet-
).
ultipotent and stem cell (F) populations in mice analyzed in (A) presented as
ted recipient and donor populations. Loading control; genomic PCR for CD45.
one marrow (WBM) or c-Kit-positive bone marrow cells derived from primary
r of recipients transplanted; WBM; n = 5, c-Kit+; n = 4. Grey bar indicates donor
ts presented as percentage (%) of donor. Error bars represent SEM.
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Figure 6. Transient Expression of Defined Transcription Factors in Myeloid Effector Cells Is Sufficient Instill Them with Progenitor Activity
In Vitro and Long-Term Multilineage Transplantation Potential In Vivo
(A) Schematic representation of experimental strategy for assaying the colony forming potential of 8-TF transduced peripheral blood cells.
(B) Colony number and type arising in methylcellulose from peripheral blood cells from recipient (left-most lanes) or donor-derived cells from a recipient
transplanted with pro-/pre-B cells transduced with 8-TF or 8-TFPoly cocktail, plus (+) or minus () exposure to doxycycline. Results from individual mouse
performed in triplicate are shown.
(legend continued on next page)
560 Cell 157, 549–564, April 24, 2014 ª2014 Elsevier Inc.
(Hlf, Meis1, Lmo2, Mycn, Pbx1, and Runx1t1) are proto-onco-
genes suggests that iHSC reprogramming likely involves the
activation and/or repression of gene networks common to
stem cells and cancer cells (Reya et al., 2001). This is also
consistent with the finding that virtually all the transcription fac-
tors required for HSC formation, maintenance, or lineage
commitment are targeted by somatic mutation or translocation
in hematologic malignancy (Orkin and Zon, 2008). Insights into
how individual reprogramming factors may mediate their activity
has been provided by recent studies. In one study, Lmo2 overex-
pression in T cell progenitors led to a preleukemic state with sus-
tained self-renewal yet without blocking T cell differentiation
potential (McCormack et al., 2010). Similarly, ectopic expression
of Hlf in committed progenitors imbued themwith sustained self-
renewal activity ex vivo without blocking differentiation potential
(Gazit et al., 2013), although this activity was insufficient to
impart HSC potential onto downstream progenitors in vivo
(R.G., B.S.G., D.J.R. unpublished data). These studies show
that while expression of Hlf or Lmo2 can instill some of the func-
tional and molecular properties of HSCs onto committed blood
cells, by themselves they cannot activate the full repertoire of
programs needed to establish HSC identity. In these regards, it
is interesting that whereas iHSCs generated using polycistronic
viruses exhibited expression profiles that were indistinguishable
from control HSCs, iHSCs generated using monocistronic vi-
ruses were heterogeneous at the molecular level, possibly as a
result of not receiving the full complement of reprogramming
factors.
Although the transcriptional properties of iHSCs derived under
optimal 8-TF polycistronic conditions were indistinguishable
from endogenous HSCs, further analysis will be required to
determine if the epigenetic landscape of these cells is fully reset.
In this regard, it was interesting that the donor reconstitution
observed in our experiments sometimes, though not always,
evolved over time posttransplantation, with donor-derived
chimerism and lineage potential changing over time. These re-
sults suggest that some reprogrammed iHSCs may need time
to fully reset their epigenetic landscape to achieve balanced
HSC potential, in a manner similar to the erasure of epigenetic
memory observed with continued passage of iPS cells (Polo
et al., 2010). Whether or not cell passage influences epigenetic
resetting during iHSC derivation is at this point unclear. It is plau-
sible that iHSCsmay require a period of ‘‘maturation’’ in the stem
cell niche to achieve full HSC potential. In these regards it is note-
worthy that some of the partially reprogrammed iHSCs we iden-(C) Colony number and type arising in methylcellulose from plated granulocytes, m
blood of cells pooled recipients transplanted with pro-/pre-B cells transduced with
replicates per cell type, per condition.
(D) Representative colony types and cytospins stained with May Grunwald of co
(E) Donor reconstitution of mice transplanted with ZsGr, 6-TFPoly, 8-TF or 8-T
posttransplantation. Only mice with >1% donor chimerism were considered reco
8-TFPoly; n = 8.
(F) Reconstitution of indicated peripheral blood cell lineages of mice showing >1
(G) Donor reconstitution 16 weeks posttransplant of secondary recipient mice tran
cells derived from primary recipients of 6-TFPoly, 8-TF or 8-TFPoly transduced
(indicated by ID) were transplanted into n = 5 secondary recipients each.
(H) Average reconstitution of indicated peripheral blood cell lineages presented as
See also Figures S2 and S6.tified had failed to appropriately upregulate theMpl or cKit recep-
tors suggesting that an inability to transduce signals in response
to TPO or SCF emanating from the niche may have been a factor
in the incomplete resetting of their transcriptional state.
Transcription factors play a critical role in the specification of
different lineages during development, and as such the discov-
ery of a set of transcription factors capable of activating the
gene regulatory networks underlying HSC functional identity
suggests that it may be possible to use these factors on cells
derived from pluripotent stem cells to facilitate the generation
of definitive HSCs. It will also be interesting to test if the reprog-
ramming factors we identified can be used to convert cell types
outside of the hematopoietic system to an iHSC fate in a manner
similar to the ability of the Yamanaka factors to bestow pluripo-
tency onto cells of diverse lineages. It remains possible, howev-
er, that iHSCs derivation using the factors we defined will be
limited to the blood system. In these regards it is important to
note that although our approach relied on delivery of the reprog-
ramming factors to the target cells ex vivo, it is possible that the
reintroduction of the target cells into the hematopoietic microen-
vironment via transplantation may have provided cues that were
critical for iHSC generation. Whether or not derivation of iHSCs
from blood cells or other cell types can be achieved ex vivo
without input from the hematopoietic microenvironment is un-
known, though clearly the lack of suitable culture conditions for
ex vivo HSC maintenance may preclude this. Nonetheless, the
generation of iHSCs via blood cell reprogramming represents a
powerful new experimental paradigm for studying the funda-
mental mechanisms underlying HSC identity that might eventu-
ally be lead to the derivation of transplantable stem cells with
clinical potential.
EXPERIMENTAL PROCEDURES
Identification of HSC-Enriched Factors
HSC-enriched factors were identified using microarray data (Affymetrix 430
2.0) of 40 FACs purified populations curated from the Gene Expression
Omnibus. For complete list of populations used and accession numbers see
Table S1. All data sets were subjected to quality control (QC) measures pro-
vided in the ArrayQualityMetrics package of R/Bioconductor. Data sets were
normalized (gcRMA) using R.We applied a filter in which the ratio of expression
in HSCs to all others was greater than 2.5-fold to define a list of potential HSC
regulators that was further defined by cross-referencing the literature.
Colony Forming Assays
pro-/pre-B cells and CMPs sorted from Rosa26rtTAmice were plated in 200 mL
of S-clone SF-03 media (IWAI North America) supplemented with 10 ng/mlacrophages/monocytes (Myl), B cells, and T cells purified from the peripheral
8-TFPoly cocktail plus (+) or minus () exposure to doxycycline. n = 4 biological
lonies derived in (C).
FPoly transduced Mac1+cKit- myeloid effector cells at indicated time points
nstituted. Recipients transplanted; ZsGr; n = 6, 6-TFPoly; n = 7, 8-TF; n = 6, and
% donor chimerism presented as percentage (%) of donor.
splanted noncompetitively with 53 106 donor-derived (CD45.2+) bonemarrow
Mac1+cKit- myeloid effector cells. Cells from individual primary donor mice
percentage (%) of donor. n = 5 recipients per group. Error bars represent SEM.
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Figure 7. Single-Cell Expression Profiling of iHSCs Reveals Evidence of Partial and Full Reprogramming
(A) Principal component analysis of single-cell expression data of iHSCs and the indicated control cell types. iHSCs were derived from experiments in which pro-/
pre-B cells were transducedwith the eight identified transcription factors via single (iHSC 8-TF) or polycistronic viruses (iHSC 8-TFPoly). Data for individual cells of
given type indicated in the legend.
(B) Dendrograms showing unsupervised hierarchical clustering of single-cell expression data of representative control cells, and all iHSCs generated using single
viruses (top), or polycistronic viruses (bottom) as described in (A). Dendrogram branches are color-coded according to cell types indicated in the legend.
(C) Violin plots and the correlation heatmaps showing single cell expression data of the indicated genes. Expression levels are shown with high expression in red,
and low expression in blue.
See also Figure S7, Table S3.SCF, IL-12, and TPO, with 5 ng/ml Flk-3, and 5 ng/ml IL-7 included for pro-/
pre-B cells. Viruses were added for 16 hr, followed by addition of 1.0 mg/ml
doxycycline for 24–48 hr. Cells were seeded at 10,000 cells/well (pro-/pre-B
cells) and 1,000 cells/well (CMPs), into 6-well culture plates, by transferring
the contents of the transduction wells including doxycycline into 1.75 ml/
well of M3434 methylcellulose (Stem Cell Technologies). For experiments us-
ing pro-/pre-B cells, M3434 was supplemented with 5 ng/ml Flk-3 and 5 ng/ml
IL-7. For Colony forming cell (CFC) assays involving peripheral blood of trans-
planted mice, donor-derived blood cells were sorted and cultured at 10,000
cells/well in F12 media supplemented with 10 ng/ml SCF, IL-12, and TPO
and 5 ng/ml Flk-3 and IL-7 in the presence or absence of 1.0 mg/ml doxycy-
cline for 3 days followed by transferring the contents of the transduction wells562 Cell 157, 549–564, April 24, 2014 ª2014 Elsevier Inc.including doxycycline into 1.75 ml/well of M3434 methylcellulose supple-
mented with IL7 and Flt3L as above. Colonies arising in these assays emerged
later than typically observed (10–12 days) when primary HSPCs are plated
(Gazit et al., 2013), and were thus scored at 20–22 days postplating.
Transplantation Assays
For experiments with 36-factor and 6-factor single viruses, pro-/pre-B cells or
CMPS were transduced with viruses for 2 days with doxycycline added on day
2. On day 3, transduced cells (ZsGr+) were sorted and transplanted at 13 104
cells/recipient into irradiated congenic recipients along with 2 3 105 marrow
cells. For experiments in which polycistronic viruses were used, sorted pro-/
pre-B cells or Mac1+ckit- myeloid effector cells were transduced and
transplanted without re-sorting at 2 3 106 or 5 3 106 cells per recipient into
irradiated recipients along with 2 3 105 Sca1-depleted radio-protective
bone marrow cells. Due to markedly reduced transduction efficiency of the
polycistronic viruses, recipients in experiments involving polycistronic viruses
were transplanted at greater cell numbers without presorting transduced cells.
Doxycycline was maintained in the drinking water for 2 weeks posttransplant.
Serial transplantation from pro-/pre-B cell experiments were performed by
transplanting 1 3 107 unfractionated bone marrow cells, or 1 3 104 c-kit-en-
riched bone marrow along with 2 3 105 Sca1-depleted radio-protective
bone marrow cells. Serial transplantation in myeloid effector experiments
was performed by transplanting 53 106 sorted donor-derived cells per recip-
ient. In all transplant experiments, peripheral blood analysis was performed at
4 week intervals with antibodies against Ter-119, B220, Mac1, Gr1, CD3,
CD45.1, CD45.2, and propidium iodide to discriminate dead cells.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2014.04.006.
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